CYTOR and cancer: Indeed, LINC00152 is significantly overexpressed in the vast majority of human cancers according to the TCGA datasets (http://ualcan.path.uab.edu/cgi‐bin/Pan‐cancer‐lncRNA.pl?genenam=CYTOR), and several studies demonstrated that its overexpression facilitates tumor progression and invasion (reviewed in Ref19).